The Comparative Impact of Globalization of Clinical Trials in India and China

Master's Thesis from the year 2013 in the subject Medicine - Hospital Environment, Clinical Medicine, Walden University, course: Clinical Research and Administration- General concentration, language: English, abstract: India and China have been identified by pharmaceutical companies as the future markets that

would support drug research and development in a cost efficient manner. This has become

necessary as resources to conduct clinical studies dwindle, coupled with the fact that

pharmaceutical industries are under pressure to deliver quality medicine, on time, to the public.

Exploring and examining India and Chinäs potential in a stepwise fashion provides the

opportunity to dissect the good, the bad and the ugly of globalization in a comparative approach.

This paper will cover areas like ethics in the conduct of studies, good clinical practice (GCP),

economic realities, ICH influence, intellectual property security and the role of government in

global clinical trial.